Akros Pharma Inc.



		Diseases and Conditions

		Pipeline/Products

		Alliances

		JT Pharmaceuticals R&D Expenses

JT Pharmaceuticals R&D Expenses (non-consolidated)

FY2007: approximately $229MM (1$=100.19JPY)
FY2006: approximately $185MM (1$=118.05JPY)
FY2005: approximately $164MM (1$=117.47JPY)
FY2004: approximately $187MM (1$=107.39JPY)